James Williams will become Sun Biomedical's new chairman if the deal is successful.

Sun Biomedical buys Melbourne firm for $8.3m

Local biotech firm Sun Biomedical has announced plans to buy Melbourne-based Dimerix Bioscience in exchange for a share package worth about $8.3 million.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Included in the following lists:

Share Transactions

$0 Bought
$0 Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer